In vitro fertilisation (IVF) is a process of fertilisation where an egg is combined with sperm outside the body, in vitro ("in glass"). The process involves monitoring and stimulating a woman's ovulatory process, removing an ovum or ova (egg or eggs) from the woman's ovaries and letting sperm fertilise them in a liquid in a laboratory. The fertilised egg (zygote) undergoes embryo culture for 2–6 days, and is then transferred to the same or another woman's uterus, with the intention of establishing a successful pregnancy.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for IVF in US$ by following Product Segments.: Intracytoplasmic Sperm Injection (ICSI), Frozen Embryo Replacement (FER) and Pre-implantation Genetic Diagnosis (PGD)
Company profiles are primarily based on public domain information including company
Vitrolife AB
EMD Serono Inc
Irvine scientific
Cooper Surgical Inc
Cook Medical Inc
Thermo Fisher Scientific Inc
Genea Biomedx
Auxogyn, Inc
Oxford Gene Technology
Ovascience

Market Analysis and Insights: Global IVF Market
The global IVF market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global IVF market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global IVF market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global IVF market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global IVF market.

Global IVF Scope and Market Size
IVF market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global IVF market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Intracytoplasmic Sperm Injection (ICSI)
Frozen Embryo Replacement (FER)
Pre-implantation Genetic Diagnosis (PGD)

Segment by Application
Clone
Transgenic
Embryonic Stem Cell Isolation and Culture
Test Tube Baby

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Vitrolife AB
EMD Serono Inc
Irvine scientific
Cooper Surgical Inc
Cook Medical Inc
Thermo Fisher Scientific Inc
Genea Biomedx
Auxogyn, Inc
Oxford Gene Technology
Ovascience